MyHomeDoctor - Suivi des patients après une chirurgie ambulatoire

The latest studies inserted

Kusajili is updated regularly with data from the following sources: ACTRN, EU Clinical Trials Register, GlaxoSmithKline (GSK) Clinical Study Register, Clinical Trials Search Portal provides, ISRCTN, JPRN, ClinicalTrials - NCT, Pfizer, Takeda, Pubmed.

Spotlight on 3 studies

Regularly we prefer 3 studies to help the inclusion of patients.

SIOP CNS GCT II: Prospective Trial for the Diagnosis and Treatment of Children, Adolescents and Young Adults With Intracranial Germ Cell Tumors

More information

Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates

The primary hypothesis is that preterm infants who are less than or equal to 32 weeks gestation and weigh 1001-2500 grams at birth will have an increase in weight gain with a feeding goal of 180-200 ml/kg/day more than the commonly used feeding goal of 140-160 ml/kg/day

More information

Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery

This randomized phase II trial studies how well erlotinib hydrochloride works in treating patients with bladder cancer undergoing surgery. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

More information

KUSAJILI ?

Kusajili is a protean search engine that addresses the need to simplify access to registers and patient inclusions.
Kusajili makes it possible to find in a few clicks, the numerous French and international trials referenced.
Kusajili, associated with MyHomeDoctor, facilitates multicenter clinical trials.
Docteur CRETON, Créateur de KUSAJILI

More information